Common Stock, Shares, Outstanding of Nabriva Therapeutics plc from 31 Dec 2016 to 30 Jun 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nabriva Therapeutics plc quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Jun 2023.
  • Nabriva Therapeutics plc Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2023 was 3,230,837, a 95% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Nabriva Therapeutics plc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 3,230,837 -61,349,374 -95% 30 Jun 2023 10-Q 19 Oct 2023 2023 Q2
Q1 2023 3,201,495 -58,523,741 -95% 31 Mar 2023 10-Q 22 May 2023 2023 Q1
Q4 2022 3,201,417 +932,805 +41% 31 Dec 2022 10-Q 19 Oct 2023 2023 Q2
Q3 2022 3,021,368 -51,294,124 -94% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 64,580,211 +14,842,659 +30% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 61,725,236 +26,312,415 +74% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 2,268,612 -18,810,169 -89% 31 Dec 2021 10-K 17 Apr 2023 2022 FY
Q3 2021 54,315,492 -95,690,940 -64% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 49,737,552 -93,227,931 -65% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 35,412,821 -59,696,226 -63% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 21,078,781 +11,624,270 +123% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 150,006,432 +72,012,225 +92% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 142,965,483 +70,059,190 +96% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 95,109,047 +23,773,067 +33% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 9,454,511 -57,564,583 -86% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 77,994,207 +11,510,048 +17% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 72,906,293 +31,946,841 +78% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 71,335,980 +31,102,113 +77% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 67,019,094 +30,311,409 +83% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 66,484,159 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 40,959,452 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 40,233,867 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 36,707,685 +33,987,990 +1250% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q4 2016 2,719,695 31 Dec 2016 10-K 16 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.